Villahermosa, Jusellene S.

HRN: 20-82-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2023
CEFTRIAXONE 1G (VIAL)
01/10/2023
01/17/2023
IVT
2grams
OD
T/c Urosepsis Secondary To Obstructive Uropathy From Cervical Cancer
Waiting Final Action 
01/16/2023
CEFTRIAXONE 1G (VIAL)
01/16/2023
01/18/2023
IV
2gOD
Od
S/p Cervical Punch Biopsy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: